Scarica l'app Stockscreener
33.87
7.18%
-2.62
Precedente Chiudi:
$36.49
Aprire:
$35.05
Volume 24 ore:
5,498
Relative Volume:
0.30
Capitalizzazione di mercato:
$133.38M
Reddito:
$17,000
Utile/perdita netta:
$-23.87M
Rapporto P/E:
-10.86
EPS:
-3.12
Flusso di cassa netto:
$-22.03M
1 W Prestazione:
+16.71%
1M Prestazione:
-9.24%
6M Prestazione:
+141.41%
1 anno Prestazione:
+59.76%
Intervallo 1D:
$33.77
$35.77
Intervallo di 1 settimana:
$28.98
$37.98
Portata 52W:
$14.00
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Nome
Vtv Therapeutics Inc
Settore
Industria
Telefono
336-841-0300
Indirizzo
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
33.87 | 143.70M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-23 | Iniziato | Roth Capital | Buy |
| 2026-01-05 | Iniziato | TD Cowen | Buy |
| 2025-11-19 | Iniziato | BTIG Research | Buy |
| 2019-05-30 | Iniziato | H.C. Wainwright | Buy |
| 2018-04-10 | Downgrade | Stifel | Buy → Hold |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-08 | Iniziato | Northland Capital | Outperform |
| 2016-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2015-09-04 | Iniziato | Canaccord Genuity | Buy |
| 2015-08-24 | Iniziato | Piper Jaffray | Overweight |
| 2015-08-24 | Iniziato | Stifel | Buy |
Mostra tutto
Vtv Therapeutics Inc Borsa (VTVT) Ultime notizie
Why vTv Therapeutics Inc. stock could see breakout soonJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - mfd.ru
vTv Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Type 1 diabetes drug developer vTv set for two investor conferences - Stock Titan
Is vTv Therapeutics Inc.’s ROE strong enoughQuarterly Growth Report & Smart Allocation Stock Reports - mfd.ru
Aug Retail: Does vTv Therapeutics Inc have strong fundamentalsEarnings Overview Report & Stepwise Swing Trade Plans - baoquankhu1.vn
(VTVT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Q1 EPS Forecast for vTv Therapeutics Increased by Analyst - Defense World
HC Wainwright Boosts Earnings Estimates for vTv Therapeutics - MarketBeat
Will vTv Therapeutics Inc outperform the market in YEARQuarterly Trade Report & Stepwise Trade Signal Guides - baoquankhu1.vn
Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS) - The Globe and Mail
vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma By Investing.com - Investing.com India
vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma - Investing.com
vTv Therapeutics Expands Global HPP737 Rights with Newsoara - TipRanks
vTv Therapeutics Signs License Agreement Amendment With Newsoara Biopharma - TradingView
vTv expands Newsoara license deal for PDE4 inhibitor to global rights - Investing.com India
VTVT Expands Global Rights Agreement for PDE4 Inhibitor - GuruFocus
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewswire
Analysts Set vTv Therapeutics Inc. (NASDAQ:VTVT) Price Target at $55.25 - Defense World
VIX Spike: Is vTv Therapeutics Inc likely to announce a buybackMarket Volume Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Published on: 2026-01-29 06:19:41 - baoquankhu1.vn
VTVT: BTIG Raises Price Target to $49.00, Maintains Buy Rating | - GuruFocus
How (VTVT) Movements Inform Risk Allocation Models - Stock Traders Daily
vTv Therapeutics (NASDAQ:VTVT) Upgraded to Strong-Buy at Roth Mkm - MarketBeat
This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Roth Capital Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
Roth/MKM initiates coverage on vTv Therapeutics stock with Buy rating - Investing.com Canada
Roth Capital Initiates Coverage on VTVT with a 'Buy' Rating | VT - GuruFocus
Buyout Rumor: Does vTv Therapeutics Inc have declining or rising EPSWeekly Gains Summary & Verified Momentum Stock Alerts - baoquankhu1.vn
Published on: 2026-01-19 16:04:02 - baoquankhu1.vn
vTv Therapeutics (VTVT) upgraded to buy: Here's what you should know - MSN
Meme Stocks: Should I hold or sell Aethlon Medical Inc nowJuly 2025 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Stop Loss: Can IRDM navigate macro headwindsWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Rises By 62.3% - MarketBeat
Trading Systems Reacting to (VTVT) Volatility - Stock Traders Daily
vTv Therapeutics (VTVT) Price Target Increased by 16.19% to 48.20 - Nasdaq
Alzheimer’s Disease Market in the 7MM is projected to reach USD 34 Billion by 2034, analyses DelveInsight - The Globe and Mail
Market Pulse: What margin trends mean for vTv Therapeutics Inc stockJuly 2025 Earnings & Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Analysis Recap: Will vTv Therapeutics Inc face regulatory challengesWeekly Trade Report & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
How vTv Therapeutics Inc. stock reacts to global recession fearsTrade Ideas & Community Shared Stock Ideas - Улправда
Smart Money: Can vTv Therapeutics Inc. (5VT0) stock attract analyst upgrades2025 Growth vs Value & Target Return Focused Stock Picks - ulpravda.ru
How vTv Therapeutics Inc. (5VT0) stock reacts to new regulationsRate Hike & Free Accurate Trade Setup Notifications - Улправда
Why institutional investors increase stakes in vTv Therapeutics Inc. (5VT0) stockWeekly Risk Summary & Daily Technical Stock Forecast Reports - Улправда
P 500 performance this yearJuly 2025 Levels & Real-Time Market Trend Scan - Улправда
Momentum Shift: How vTv Therapeutics Inc. (5VT0) stock reacts to new regulations2025 AllTime Highs & Daily Stock Trend Reports - Улправда
Should I hold or sell vTv Therapeutics Inc. stock in 2025July 2025 Final Week & Growth Focused Stock Pick Reports - Улправда
Brokerages Set vTv Therapeutics Inc. (NASDAQ:VTVT) PT at $51.33 - Defense World
Is vTv Therapeutics Inc. stock supported by innovation pipeline2026 world cup usa national team group stage goalkeepers build up play knockout prediction statistical analysis - Улправда
vTv Therapeutics (NASDAQ:VTVT) Now Covered by Analysts at TD Cowen - Defense World
TD Cowen Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
Vtv Therapeutics Inc Azioni (VTVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):